Immuneering Corporation (IMRX)
NASDAQ: IMRX
· Real-Time Price · USD
5.48
0.02 (0.37%)
At close: Sep 05, 2025, 11:30 AM
0.37% (1D)
| Bid | 3.89 |
| Market Cap | 198.95M |
| Revenue (ttm) | 726.33K |
| Net Income (ttm) | -62.13M |
| EPS (ttm) | -1.9 |
| PE Ratio (ttm) | -2.88 |
| Forward PE | -3.29 |
| Analyst | Buy |
| Ask | 6.73 |
| Volume | 220,244 |
| Avg. Volume (20D) | 1,476,846 |
| Open | 5.48 |
| Previous Close | 5.46 |
| Day's Range | 5.17 - 5.52 |
| 52-Week Range | 1.10 - 6.35 |
| Beta | 0.43 |
About IMRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+34.99%
Immuneering shares are trading higher after the co...
Unlock content with
Pro Subscription
2 weeks ago
+23.68%
Immuneering shares are trading higher after the company reported a Q2 EPS beat and announced it has filed for a $300 million mixed-shelf offering.
